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ABSTRACT  
 
 
Introduction:  
 
The peritoneal cavity is frequently involved in a variety of diseases, both benign and 
malignant. Cross-sectional imaging plays an important role to diagnose and to assess 
the extent of peritoneal disease; however, there is considerable overlap in CT findings 
of the different disease conditions presenting with peritoneal spread. We included and 
evaluated such patients who presented with peritoneal spread of disease. 
Objectives:  
 
• To assess the diagnostic accuracy of CT in differentiating the various etiologies 
of diffuse peritoneal disease  
• To estimate the spectrum and identify the differentiating features of varying 
etiologies of diffuse peritoneal disease  
Methods:  
 
All patients with peritoneal disease who had abdominal CT and subsequently underwent 
omental biopsies (both surgical and ultrasound guided) from 1st January 2016 to 31st 
December 2017, were included in our study.  The imaging findings were reviewed in 
PACS by 2 radiologists independently, who were blinded to the patient demographics, 
the clinical findings and the histopathologic results. The CT findings were assessed 
under various specific headings to describe peritoneal, mesenteric or omental 
involvement and few general features like ascites, lymphadenopathy and splenomegaly. 
The CT findings were then compared and evaluated with histopathology as the gold 
standard. 
 xii 
Results:  
 
We found that higher age, increasing omental thickness, omental caking, larger 
mesenteric/peritoneal nodules, visceral scalloping, free ascites, serosal involvement and 
bilaterality of pleural effusion were associated with malignant etiology while 
mesenteric thickening/stranding, mesenteric adenopathy, necrotic lymph nodes, 
splenomegaly and higher attenuation (>20HU) of ascitic fluid were more associated 
with benign etiology.  
Overall, CT had a high diagnostic accuracy for differentiating benign and malignant 
etiologies of diffuse peritoneal disease with good sensitivity and specificity with 
substantial interobserver agreement. 
 
Keywords: Omental biopsy, diffuse peritoneal disease, CT findings, histopathology.  
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INTRODUCTION 
 
The peritoneum, a complex serosal membrane lining the abdominal cavity and covering 
the visceral organs encloses a potential space called the peritoneal cavity. This cavity is 
frequently involved in a variety of benign and malignant processes. These include TB, 
lymphoma, primary malignancies, metastases from various other primaries like ovaries, 
GI tract etc. While secondary involvement of the peritoneum is more common, together 
with primary tumors it often becomes a diagnostic challenge (1). Cross-sectional 
imaging plays an important role to diagnose and to assess the extent of peritoneal 
disease; however, there is considerable overlap in CT findings of the different disease 
conditions presenting with peritoneal spread. We included and evaluated such patients 
who presented with peritoneal spread of disease. 
Our study included patients who had undergone contrast enhanced abdomino-pelvic CT 
scan in our department and subsequently underwent omental biopsies, both surgical and 
ultrasound guided. Blinded to the patient demographics, the clinical findings and the 
histopathologic results the imaging findings were reviewed by 2 radiologists 
independently. The CT findings were assessed under various specific headings which 
were predominantly used to describe peritoneal, omental and mesenteric involvement 
like thickening, stranding, nodularity etc. and also general features like ascites, 
lymphadenopathy and splenomegaly. The histopathology reports were assessed and the 
variables on CT were evaluated with histopathology as the gold standard. 
                        
  
 2 
AIMS AND OBJECTIVES 
 
AIMS: To assess the role of CT in evaluating diffuse peritoneal disease  
 
OBJECTIVES: 
Primary: 
• To assess the diagnostic accuracy of CT in differentiating the various etiologies 
of diffuse peritoneal disease with histopathology co-relation  
Secondary: 
• To estimate the spectrum of diseases causing diffuse peritoneal disease in a 
tertiary care centre  
• To describe the various manifestations of diseases that cause peritoneal disease 
• To identify differentiating features among these that would aid in identifying 
etiology  
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REVIEW OF LITERATURE 
 
Introduction 
Even though the peritoneum can be affected by both malignant and benign disease 
processes, there may be considerable overlap in the imaging appearances of peritoneal 
involvement in these two vastly distinct disease processes with contrasting prognosis.  
A thorough knowledge of the peritoneal anatomy is thus crucial in understanding the 
numerous pathologic processes involved. 
Anatomy 
The peritoneum is a translucent, thin and the largest complex serosal membrane in the 
body which lines the abdominal cavity, forms the mesenteries and covers the abdomino-
pelvic viscera partially or completely. The peritoneum lining the abdominal wall is the 
parietal and the peritoneum covering a viscus or an organ is called the visceral 
peritoneum. The peritoneum is composed of a single layer of simple cuboidal 
epithelium called the mesothelium. The potential space between the parietal and the 
visceral peritoneum is called the peritoneal cavity. The peritoneal surfaces are 
lubricated by a thin film of serous fluid, approximately 50 –100 mL which separates the 
parietal and visceral layers of peritoneum. In men, the peritoneal cavity is closed, 
whereas it communicates with the extra-peritoneum exteriorly through the fallopian 
tubes, uterus and the vagina in women (2).  
Adequate knowledge of the embryology of the peritoneal development is primary to 
comprehend its structure and function. First, the primitive gut occupies the peritoneal 
cavity and is supported by a dorsal and ventral mesentery dividing the peritoneal cavity 
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into a right and left compartment. Along and within the dorsal and the ventral 
mesenteries occurs the development of viscera.  
Liver develops in the ventral mesentery and within the dorsal mesentery develops the 
spleen and the pancreas. With continued growth, rotation, folding and reflection the 
dorsal and ventral mesentery form the different ligaments, omentum and mesenteries to 
finally form the compartmentalized adult peritoneal space.  
 
Figure 1: The embryologic development of the dorsal and ventral mesentery at 4th  (left), 5th  (center), and 6th 
(right) weeks of gestation, wherein the ventral part of the ventral mesentery becomes the [1] falciform ligament, 
the dorsal part of the ventral mesentery becomes the [2] lesser omentum, the ventral part of the dorsal mesentery 
becomes the [3] gastrosplenic ligament and the dorsal part of the dorsal mesentery becomes the [4] splenorenal 
ligament (2). 
Double layers or folds of peritoneum form the peritoneal ligaments that support an 
organ within the peritoneal cavity and which pass from one organ to another or from an 
organ to one of the abdominal walls. The ventral and the dorsal mesentery gives rise to 
most of the abdominal ligaments.  
The omentum is a double layer of peritoneum that attaches the stomach and the 
duodenal bulb to another viscus.  The lesser omentum is the fold of peritoneum that 
attaches the lesser curvature of the stomach and the duodenal bulb to the porta hepatis 
of the liver superiorly and is formed by the gastrohepatic and hepatoduodenal ligaments. 
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The gastrohepatic ligament contains the left gastric artery and the coronary vein while 
the hepatoduodenal ligament contains the hepatic artery, the common hepatic ducts, the 
portal vein and part of the cystic duct.  
The greater omentum hangs from the greater curvature of the stomach akin to an apron 
and is the largest peritoneal fold, consisting of a double sheet folded upon itself,  thus,  
made up of four layers. From the greater curvature of the stomach and 
proximal duodenum the two layers of peritoneum descend anterior to the small bowel 
for an inconsistent distance and then turns superiorly so as to insert into the 
anterosuperior aspect of the transverse colon. The left border is continuous with the 
gastro-splenic ligament and the right extends until the origin of the duodenum.  
The gastro-splenic ligament is formed by the ventral part of the dorsal mesentery which 
extends from the greater curvature of the stomach to the splenic hilum. It contains the 
short gastric vessels and forms a site for collateral circulation during portal vein or 
splenic vein thrombosis.  
The dorsal most aspect of the dorsal mesentery forms the spleno-renal ligament, 
contains the pancreatic tail and in patients with portal hypertension, collateral 
circulation may develop within this ligament.  
The triangular and the falciform ligaments are formed by the fusion of peritoneal 
reflections and form the suspensory ligaments of liver. The superior and the inferior 
coronary ligament reflections fuse to form the triangular ligaments. The left triangular 
ligament is short and does not compartmentalize the left sub-phrenic space while on the 
other hand the right triangular ligament is long and compartmentalizes the right sub-
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phrenic and sub-hepatic spaces. The bare area of the liver is outlined by the triangular 
ligaments. 
The falciform ligament, a remnant of the ventral mesentery is a thin and broad 
peritoneal ligament. It contains the paraumbilical veins, the round ligament and the 
obliterated umbilical vein. It divides the left and right sub-phrenic compartments 
incompletely and may allow passage of fluid from one side to the other. 
The mesentery is a double layer of peritoneum that encloses the intestines and connects 
them to the posterior abdominal wall. The mesenteric contains lymph nodes, blood 
vessels, nerves and fat. Mesentery includes the mesoappendix, small bowel mesentery, 
the transverse mesocolon and the sigmoid mesocolon.  
A wide fold of peritoneum connecting the transverse colon to the posterior abdominal 
wall forms the transverse mesocolon. It is a derivative of dorsal mesentery and contains: 
• transverse colon (in the free margin) 
• middle colic vessels and their branches  
• autonomic nerve fibers  
• lymphatics and lymph nodes  
• extraperitoneal fatty tissue 
Pancreatic head tumors with metastases to the transverse mesocolon are rendered 
unresectable owing to many small vessels that make vascular control difficult.  
The small bowel mesentery, extending from the ligament of Treitz to the ileocecal valve 
is a broad, fan shaped fold of peritoneum that attaches the jejunum and the ileum to the 
posterior abdominal wall. It courses from left to right, passing anterior to the horizontal 
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part of the duodenum, the abdominal aorta, the inferior vena cava, the right ureter and 
the right psoas muscle successively. The intestinal border is thrown into a number of 
characteristic pleats or frills. It contains the jejunal and ileal branches of the superior 
mesenteric arteries and their accompanying veins, nerves and lymphatics.  
The peritoneal fold attaching the sigmoid to the posterior pelvic wall forms the sigmoid 
mesocolon and contains the sigmoidal and the superior rectal vessels. The fold of 
peritoneum attached to the lower end of small bowel mesentery covering the vermiform 
appendix and at times suspending the cecum forms the mesoappendix containing the 
appendiceal vessels.  
 
Figure 2: Posterior peritoneal reflections forming the intra-abdominal spaces (1).  
(a) Cut surface of the transverse mesocolon (arrow), dividing the peritoneum into supramesocolic and 
inframesocolic compartments. The root of the small bowel mesentery (arrowhead) is dividing the inframesocolic 
compartment into the right and the left infracolic spaces. Also shown is the cut surface of the sigmoid mesentery  
(b) Pathways of intraperitoneal fluid flow with the four predominant stasis sites (*) of ascitic fluid in the lower 
abdomen. 
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The various peritoneal ligaments and their attachments divide the peritoneal cavity into 
distinct and separate compartments. The transverse mesocolon divides the peritoneum 
into two major compartments known as the supra-mesocolic and the inframesocolic 
spaces.  The supra-mesocolic space is further divided into the right and the left 
supramesocolic spaces by the falciform ligament. Similarly, the small bowel mesentery 
divides the infra-mesocolic space into the right and left infra-mesocolic space. The right 
supramesocolic spaces include the hepatorenal space, right subphrenic space and the 
lesser sac, also known as the omental bursa. The lesser sac is further divided into a 
superior and an inferior recess by the peritoneal reflection of the left gastric artery.  
The right infra-mesocolic space is limited by the small bowel mesentery attachment to 
the cecum and is thus smaller compared to the left inframesocolic space which 
communicates with the pelvis.  Located lateral to the peritoneal reflections of the left 
and right sides of the colon and communicating freely with the pelvic spaces are the 
paracolic spaces. The phrenico-colic ligament partially limits the connection between 
the left subphrenic space and the left paracolic gutter. The larger right paracolic gutter 
in contrast communicates freely with the right subphrenic space.  
The rectovesical space is the most gravity-dependent space for accumulation of fluid in 
males and in females it is the rectouterine space. The pelvic spaces are divided into 
lateral and medial compartments by the medial umbilical folds containing the obliterated 
umbilical arteries.  The lateral pelvic compartment on each side is further divided by the 
inferior epigastric artery into lateral and medial inguinal fossae (2,3).  
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Figure 3: The peritoneal anatomy and the peritoneal spaces with the direction of flow (arrows) of peritoneal fluid (4). 
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Pathophysiology 
 
A variety of benign and malignant processes frequently involves the peritoneum. The 
flow of fluid within the peritoneal compartments formed by mesenteric attachments 
directs the distribution and location of the secondary disease processes. Secondary 
involvement of peritoneum in the form of tumors and tumor like lesions form a distinct 
group of pathologic disorders. Although they imitate primary peritoneal tumors, the 
secondary involvement of peritoneum is more common than primary lesions (1). This 
often presents a diagnostic challenge. In the present age, cross-sectional imaging plays 
a central role in the diagnosis and evaluation of the extent of the disease (4). The initial 
imaging modality is most often the abdomino-pelvic CT which enables identification 
of peritoneal disease. The accurate description of the severity of the disease and 
radiologist’s exact localization of entire affected sites provide important direction to 
clinicians in management of the disease (5). Even though CT plays a vital role in the 
detection of peritoneal tumors and its mimics, owing to the overlap of imaging findings 
the exact diagnosis and characterization of lesions is often challenging (6). 
Nevertheless, based on thorough assessment of computed tomography features and 
fitting clinical context a number of differential diagnoses become easier to distinguish.  
Marin D et al in their study on a cohort of 18 patients with known or suspected 
peritoneal carcinomatosis, found extremely high sensitivity (89%) of CT in detecting 
lesions 0.5 cm or more in diameter. Lesions less than 0.5 cm showed a markedly lower 
sensitivity (43%). A low false positive (9%) rate was noted in the detection of peritoneal 
metastases, probably owing to the relatively low number of peritoneal malignancy 
mimics that are of benign etiology. The solitary noteworthy exception was that the 
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mesentery accounted for 4 of the 10 false-positive findings, with 43% of relative 
specificity of CT. They postulated that this may be linked to the variety of pathologic 
conditions which can affect the mesentery, including inflammatory, vascular and 
malignant disorders with subsequent manifestation of almost indistinguishable findings 
on CT. Their study demonstrated that use of 64-section MDCT with the aid of isotropic 
reformatted sagittal and coronal images was found to be extremely effective technique 
in the detection of peritoneal metastases, especially in areas like the hemi-diaphragms, 
the mesentery, the dome of the liver and the pelvis which are sub-optimally assessed on 
axial imaging alone with sensitivity, specificity, positive and negative predictive values 
of 75%, 92%, 90% and 79% respectively (7). Thus, to assess areas that are difficult to 
evaluate on axial images as well as to confirm the presence of metastatic peritoneal 
implants, multiplanar imaging shows immense potential (8).  
Although not a comprehensive list, malignant peritoneal mesothelioma, peritoneal 
lymphomatosis, peritoneal TB and pseudomyxoma peritonei are the chief disorders that 
imitate peritoneal carcinomatosis (9). The most common diffuse disease of the 
peritoneum is peritoneal carcinomatosis which primarily is defined as disseminated 
intraperitoneal tumor of origin other than peritoneum itself. A clear understanding of 
the dissemination routes of peritoneal carcinomatosis and the flow dynamics of 
peritoneal circulation is of utmost importance to recognize the signs of peritoneal 
carcinomatosis. The spread is mainly by the following four routes:  
1) Hematogenous  
2) Contiguous spread 
3) Lymphatic  
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4) Peritoneal surface spread by gravity and peristalsis  
Peritoneal carcinomatosis 
 
Peritoneal carcinomatosis can be either focal or diffuse. On sonography, ascitic fluid 
associated with peritoneal carcinomatosis may contain hypoechoic particulate matter 
reflecting proteinaceous exudate. Peritoneal nodules are generally hypoechoic or sheet 
like. Ascites is a common finding, formed as a result of obstruction of the sub-phrenic 
lymphatic vessels as well as increased capillary permeability causing excessive 
production of peritoneal fluid. Omental infiltration is usually in the form of echogenic 
plaques which are seen attached to the abdominal wall or floating in ascites. There may 
be replacement of omental fat with fibrosis and tumor leading to the characteristic 
appearance of “omental caking.” New onset ascites, location of the ascitic fluid and a 
peritoneum which is thickened, shows nodularity and enhances should raise the 
suspicion of a malignant process. Mesentery of the small bowel may get infiltrated 
forming nodules, causing stiffening, straightening and increase in density of mesenteric 
vasculature giving a stellate appearance on CT which is very characteristic. A common 
complication of peritoneal carcinomatosis is small bowel obstruction owing to 
infiltration by tumor (1,9).  
Malignant mesothelioma 
 
Malignant mesothelioma, an aggressive neoplasm that arises from the mesothelial cells 
of the serosal membranes of the body cavities including the peritoneum, pleura, 
pericardium or the tunica vaginalis of testis with peritoneum accounting for about 10-
15%. The pathological subtypes of peritoneal mesothelioma include the well 
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differentiated papillary mesothelioma, cystic mesothelioma and malignant 
mesothelioma. History of heavy and prolonged asbestos exposure is seen in more than 
half the population affected with malignant mesothelioma, and predominantly includes 
older men, during the fifth and sixth decades. Thoracic CT examination should be 
performed if and when calcified peritoneal plaques are observed, to look for signs of 
asbestos exposure which include calcified pleural plaques and thickening of the pleura. 
Peritoneal involvement in malignant mesothelioma can be either diffuse or localized 
mass like. The wet form of the disease which presents with abdominal discomfort and 
distention involves diffuse sheet like peritoneal thickening, nodularity, omental masses 
and ascites, which is usually moderate in amount. The dry form, which usually presents 
with abdominal pain is associated with localized peritoneal based masses with none or 
minimal ascites. The tumor infiltrates rapidly within the peritoneal cavity with rare 
nodal and distant metastatic spread, accounting for an expected median survival of only 
10 months at the time of diagnosis. The cystic mesothelioma subtype of peritoneal 
mesothelioma is rare and has no association with asbestos exposure. Usually seen in 
young to middle aged women with a characteristic involvement of the pelvis, this 
subtype is known to be associated with pelvic inflammatory disease or past history of 
abdominal surgery. Imaging features depend on the gross morphology which include 
grape like multilocular cystic, unilocular cystic or multiple unilocular cystic masses. 
Although cystic mesothelioma is considered benign, malignant transformation has been 
documented.  The well-differentiated papillary mesothelioma is a rare indolent subtype 
and predominantly occurs in women in the reproductive age. Similar to the cystic 
mesothelioma, this subtype is not associated with asbestos exposure either and 
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generally behaves in a benign fashion. On imaging, the findings are quite non-specific 
and usually include thickening of the peritoneum, nodularity, infiltration of the 
omentum and, ascites (10,11).   
Lymphoma 
 
In lymphoma, the peritoneum could be involved either primarily or as a secondary 
process. Primary peritoneal lymphomas, also known as body cavity-based lymphomas 
are rare and usually found in immunocompromised patients, particularly those infected 
with HIV. Even though the lymphoma remains limited to the originating cavity in most 
patients, these have a poor prognosis as they are aggressive and high grade. The 
secondary involvement of peritoneum does not have any predilection for 
immunocompromised state and can occur in general population as well. Secondary 
lymphomatosis involves ascites, diffuse thickening, enhancement and nodularity of the 
peritoneum, along with caking and infiltration of omentum and small bowel mesentery  
Although these findings are also seen in peritoneal carcinomatosis, the presence of 
splenomegaly and lymphadenopathy (especially retrocrural or mesenteric) may instead 
point towards lymphomatosis. On the other hand, primary effusion lymphoma 
manifests most commonly as malignant ascites with no associated lymph nodal 
enlargement or discrete lesions (1,4). 
Peritoneal tuberculosis 
 
The most common presentation of abdominal tuberculosis affecting the abdomen is in 
the form of peritoneal tuberculosis and involves the peritoneal cavity, omentum and the 
mesentery. The route of spread is mostly haematogenous, other routes proposed being 
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rupture of infected lymph nodes, direct extension from gastrointestinal dissemination 
and not infrequently from infection of the genitourinary tract. Peritoneal TB is typically 
divided grossly into dry, wet and the fibrous types. There is considerable overlap of 
features among the three types with smooth peritoneal thickening being a consistent 
feature.  The commonest type is the wet type (90%) and usually manifests as ascites 
which may be loculated or free with diffuse and smooth thickening of the peritoneum. 
The ascitic fluid is usually of high attenuation owing to high cellular and protein 
content. The finding of ascites with fat-fluid level is found to be highly specific for 
tuberculous ascites (12). The second common type (7%) is the fibrous type which 
predominantly involves thickening of the omentum, fixing of the bowel loops with 
loculated ascites. The least common type is the dry type (3%) which involves thickened 
peritoneum and mesentery, caseous nodules, lymphadenopathy with peritoneal and 
fibrinous adhesions. Lymphadenopathy is most often associated with necrosis and 
calcification. In upto 80% of patients, the omentum may be altered and shows diffuse 
infiltration, nodularity and caking which is less frequent (< 20%) compared to 
peritoneal carcinomatosis (40%). Another common finding is the involvement of 
mesentery which may be mild in the form of striations, engorgement of mesenteric 
vessels, densification of fat to a more widespread and pronounced infiltration and 
nodularity of the mesenteric leaves. The varied range of clinical appearances along with 
and overlapping imaging findings still make the diagnosis of peritoneal tuberculosis an 
arduous challenge (3,12).   
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Pseudomyxoma peritonei 
 
Pseudomyxoma peritonei, also known as jelly beans is a clinical / radiologic descriptive 
entity which describes the finding of copious amount of thick, gelatinous or mucinous 
material covering the peritoneal cavity surfaces and mucinous ascites. It is a rare 
condition, more common in women than men and with a mean age of 49 years at 
diagnosis.  Common clinical presentation is progressive pain in the abdomen, with 
abdominal distension and loss of weight. Often, when pseudomyxoma peritonei is 
present predominantly in the right lower quadrant, patients present with a clinical 
picture similar to those of appendicitis. Pathologically, pseudomyxoma has been 
divided into pseudomyxoma peritonei and peritoneal mucinous carcinomatosis. The 
former variety contains benign or cells from well-differentiated (low-grade) mucinous 
carcinomas. It tends to spread along the peritoneal surfaces without invading the stroma 
and is thus amenable to surgical debulking and has a better prognosis. The latter on the 
other hand has a larger fibrotic component which may be adherent to all peritoneal 
surfaces. Pathologically, it is characterized by high grade, invasive mucinous carcinoma 
which is moderate or poorly differentiated and originates from mucinous carcinoma of 
the gastrointestinal tract, pancreas, gallbladder or the ovary. On plain abdominal 
radiography, increased opacification of the entire abdomen with poorly defined 
intraabdominal organs and obliterated psoas margins may be seen. There may be 
obscuration of the inferior hepatic margin or medial displacement of tip of the liver due 
to focal mucin collections in the sub-hepatic space. Mucin in the para-colic gutters may 
displace the ascending and the descending colons centrally. Symmetrical areas of 
opacity are seen on either side of the bladder when mucin is present in the para-vesical 
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spaces. Calcifications may be seen within pseudomyxoma and are usually faint, 
amorphous or curvilinear.  Echogenic septations with non-mobile echoes may be seen 
on sonography in the ascitic fluid owing to the gelatinous nature of pseudomyxoma 
peritonei. On CT, multiple focal low attenuation areas causing scalloping but without 
any direct infiltration of the intraperitoneal upper abdominal organs, typically the liver 
and the spleen may be seen. Parietal peritoneal and omental involvement may be seen 
in the form of echogenic sheet like masses. The intestines are echogenic and centrally 
displaced surrounded by hypoechoic gelatinous fluid giving a starburst appearance. 
Infiltration of the abdominal viscera with omental caking, mesenteric or retroperitoneal 
lymph node enlargement and pleural effusion or masses should raise the possibility of 
mucinous carcinomatosis as diagnosis. Furthermore, the volume of mucin is 
comparatively lesser in mucinous peritoneal carcinomatosis. Careful inspection of the 
appendix and ovaries should be done in all newly diagnosed cases to rule out a primary 
(1,4).   
Peritoneal sarcomatosis 
 
Peritoneal sarcomatosis, a rare peritoneal surface malignancy is the intraperitoneal 
spread of sarcoma. These arise from either recurrence of intraabdominal sarcomas or as 
metastases from extremity sarcomas. Common tumors giving rise to peritoneal 
sarcomatosis are gastrointestinal stromal tumors (GISTs), leiomyosarcomas, and 
liposarcomas. The features of peritoneal sarcomatosis are quite similar to that of 
peritoneal carcinomatosis. However, unlike carcinomatosis, the implants in the 
peritoneum from sarcomas are more often deforming, spherical, mostly vascular, and is 
usually associated with minimal ascites. The incidence of hydronephrosis and bowel 
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obstruction is lesser in sarcomatosis. GIST is the most common sarcoma associated 
with peritoneal sarcomatosis. On imaging these are mostly seen as large, 
heterogeneously enhancing necrotic masses with minimal or no ascites. The most 
common retroperitoneal sarcoma is the liposarcoma. Most subtypes are well 
differentiated and dedifferentiated with decrease in the macroscopic fat corresponding 
to increase in aggressiveness of histological subtypes(13,14). Peritoneal spread is 
mostly seen with the myxoid subtype and are seen as low density homogenous masses. 
The peritoneal masses in retroperitoneal liposarcoma are heterogenous with variable 
amounts of fat and soft tissue, often with mild to moderate enhancement of the soft 
tissue component and occasional calcification. Primary peritoneal involvement by 
leiomyosarcoma, a malignancy of smooth muscle origin occurs rarely and may be seen 
as diffuse thickening of the peritoneum or as focal discrete masses. The peritoneal 
implants are similar to the ones in liposarcoma and in addition are larger and intensely 
enhancing. Hemoperitoneum or bowel obstruction are the associated complications. 
Ascites is not a common finding in either of these conditions (15).  
Splenosis and leiomyomatosis 
 
Dissemination of splenic tissue within the peritoneal cavity causes a condition known 
as splenosis. It is usually associated with trauma or surgery causing disruption of the 
splenic capsule. Along with peritoneal cavity, splenosis can also be seen along the 
diaphragmatic surface within the thoracic cavity as single or multiple well-defined 
lobulated or round soft tissue masses with attenuation similar to the native spleen. In 
indeterminate cases, nuclear imaging could be used to demonstrate splenic tissue (4,16).  
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Disseminated peritoneal leiomyomatosis is an extremely rare benign disorder 
characterized by multiple leiomyomas in the peritoneum. It is an incidental finding in 
women in the reproductive age group, associated with elevated reproductive hormones 
and is primarily located in the grater omentum and the pelvic peritoneum and less 
commonly involves the superior areas of the peritoneum. On CT these are seen as 
multiple peritoneal nodules which are diffusely spread and often with a soft tissue pelvic 
mass with lobules which causes displacement of the pelvic organs.  There is no 
associated enlargement of lymph nodes. On MRI, these masses have signal intensity 
similar to skeletal and smooth muscles on T1 and T2 with variable contrast 
enhancement.  The diagnosis is usually made by image guided or surgical biopsy. This 
condition generally has an indolent course, although malignant transformation and 
recurrence has been reported (9,17).  
Endometriosis 
 
Endometriosis, a common condition affecting the peritoneal cavity of women in child 
bearing age and is characterized by functional endometrial glands and stroma being 
present outside the uterus. It commonly affects both the visceral and the parietal 
peritoneum. The mean age at diagnosis is 25-29 years with an incidence of 
approximately 10% in women of child bearing age. Patients could be completely 
asymptomatic or may present with infertility, dysmenorrhea, pelvic pain, dyspareunia 
or dysfunctional uterine bleeding. The symptoms do not necessarily co-relate with the 
stage of the disease. Pathologically, it is characterized by hemorrhagic, reddish brown 
cysts or nodules on the peritoneal surfaces. Fibrosis and peritoneal adhesions may be 
seen if the lesions are long standing. The fibrosis can distort the normal anatomy of the 
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involved structures, particularly the fallopian tubes, the ovaries, the pouch of Douglas 
and may even cause bowel obstruction owing to tethering. The ectopic endometrial 
tissue undergoes the same hormone dependent changes as is seen in the uterine 
endometrial tissue. On sonography the peritoneal involvement is in the form of non-
specific nodules or plaques on the peritoneal surfaces with no significant internal 
vascularity. These cysts are not known to resolve. On CT, endometriotic masses are 
non-specific and may be of varying density. MRI has higher specificity for the diagnosis 
of endometriotic masses and is primarily based on detection of blood products within 
the lesions. These are seen as T1 hyperintense and T2 hypointense lesions and gives the 
characteristic T2 shading pattern. Another common pattern is the presence of a low 
signal intensity rim signifying fibrosis and hemosiderin deposition on both T1 and T2 
imaging. MR is less sensitive for detection of plaque like lesions and endometrial 
implants which are small in size as these shows variable signal intensity. Additional 
techniques including fat suppressed and chemical shift imaging help in improving the 
sensitivity of MR in picking up endometriotic lesions (1).  
Gliomatosis peritonei 
 
Gliomatosis peritonei is rare condition characterized by the presence of benign, mature 
glial implants in the peritoneum. It occurs usually in association with solid or immature 
ovarian teratomas with very rare malignant transformation. On CT, the findings are very 
similar to peritoneal carcinomatosis and include peritoneal enhancing nodules and 
masses, omental caking and ascites along with a pelvic or an adnexal mass. These 
deposits are usually multilobular with homogeneous high signal intensity on T2W MR 
imaging (1,18). 
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Peritoneal echinococcosis 
 
Peritoneal echinococcosis is a rare condition caused by the parasite Echinococcus 
granulosus. It is can either be primary or secondary. Secondary involvement of the 
peritoneum from a hepatic primary is the most common presentation with the primary 
type being extremely rare. Spread outside liver or lungs is thought to be via systemic or 
lymphatic circulation. Majority of the cases are associated with previous surgery for 
hepatic HC. Asymptomatic micro-ruptures of hepatic cysts into the peritoneal cavity 
can occur spontaneously, although are rare. Peritoneal seeding may also be seen in post-
traumatic rupture of hydatid cyst in the liver. CT and MR are the imaging modalities of 
choice for assessment. On the basis of appearance, hydatid cysts can be classified into 
four types, simple cyst with no internal architecture form the type I, type II cysts contain 
the daughter cyst(s) and matrix, calcified cysts form the type III and type IV cysts are 
hydatid cysts with complications including rupture and superinfection. On CT, these 
are seen usually as multiple cysts which can arise anywhere in the peritoneal cavity with 
characteristic features including daughter cysts, cyst wall thickening, wall calcification, 
presence of internal septations and hydatid sand. Differentiating the unilocular type 1 
hydatid cyst from mesenteric or intestinal duplication cysts is difficult. Involvement of 
the retroperitoneum does not have any specific feature and can include any type of 
hydatid cyst (19–21).    
Inflammatory pseudotumor 
 
Inflammatory pseudotumor is a rare, benign, chronic inflammatory lesion which has 
been called by different names, including plasma cell granuloma and inflammatory 
myofibroblastic tumor. Symptoms secondary to mass effect are usually seen in patients 
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with intraabdominal lesions. Multiple sites may be involved including the mesentery 
and peritoneum. It has an indolent course and the systemic signs and symptoms 
including fever, weight loss, thrombocytosis, anemia and polyclonal 
hypergammaglobulinemia seen in around one fourth of the patients usually resolve after 
complete surgical resection. Incomplete surgical resections have been reported to result 
in local recurrences. Imaging findings are non-specific and may include masses with 
well-defined or infiltrating margins which reach up to the adjoining bowel segments 
and into the neighboring mesentery. These are seen as solid mesenteric masses with 
mixed echotexture and prominent vascularity on ultrasonography and color Doppler 
imaging. On CT, the enhancement pattern seen is variable with larger lesions showing 
central necrosis in the form of hypodense areas (1,22,23).   
Desmoplastic small round cell tumor  
 
Desmoplastic small round cell tumor (DSRCT) is a rare malignancy seen in adolescents 
and young adults and has a very poor prognosis. Histologically, the tumor is 
characterized by the presence of ‘‘small round blue cells’’ as are also seen in Wilm’s 
tumor, peripheral primitive neuroectodermal tumor, Ewing sarcoma, and Askin tumor. 
On CT, this is characterized by diffuse peritoneal thickening of the peritoneum, 
nodularity, masses which may demonstrate tiny calcifications, heterogeneous 
attenuation and post-contrast enhancement and ascites. On MRI, these show high signal 
intensity on T2 weighted imaging and are usually low on T1 weighted imaging. Rarely, 
it may present as a solitary peritoneal mass and the diagnosis should always be 
considered in young adults with no obvious primary organ of origin (4,24).  
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A.C. O’Neill et al in their study on a cohort of 122 patients with pathologically proven 
peritoneal spread, found distinctive patterns of involvement according to the varying 
etiology. Peritoneal sarcomatosis was associated with discrete well-defined nodules 
with a smooth outline, carcinomatosis was characterized by thickening of the 
peritoneum and omental caking, as well as absence of discrete nodules and 
lymphomatosis although similar to carcinomatosis in many aspects, was associated with 
splenomegaly, large mesenteric mass and lymphadenopathy. These findings could 
guide the radiologist in differentiating among these malignant etiologies (25).  
Ha et al in a study in 1996 to determine the potential of CT in distinguishing TB 
peritonitis from peritoneal carcinomatosis found that although most findings 
overlapped, combination of certain findings could help in differentiating the two. They 
found that mesenteric changes including thickening and macro-nodularity (size >5mm) 
was more seen in peritoneal TB (98%) than in peritoneal carcinomatosis (70%). 
Omental infiltration was more irregular in peritoneal carcinomatosis patients. 
Splenomegaly and splenic calcifications were seen more in TB peritonitis patients. 
Overall, the sensitivity of CT for predicting the diagnosis was found to be 69% for TB 
peritonitis and 91% for peritoneal carcinomatosis (26).  
Charoensak et al in 2012 conducted a similar study to differentiate CT findings between 
TB peritonitis and peritoneal carcinomatosis on a study population comprising of 
pathologically proven 27 tuberculous peritonitis and 53 peritoneal carcinomatosis 
patients. Ascites was the most common finding in tuberculous peritonitis (96.3%), 
commoner than in peritoneal carcinomatosis and was more often loculated (23.1%). 
Peritoneal abnormalities in the form of thickening and nodularity were more common 
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in peritoneal carcinomatosis than in TB peritonitis. Uniform and smooth thickening of 
the peritoneum was more frequently encountered in TB peritonitis (80%) while 
peritoneal nodules were more associated with peritoneal carcinomatosis (76.7%). 
Omental nodularity and caking were found to be more frequent in peritoneal 
carcinomatosis whereas smudge type was more common in tuberculous peritonitis 
(87.5%). Mesenteric disease in the form of thickening, nodularity and stellate 
appearance was more frequently identified in tuberculous peritonitis (88.9%). Lymph 
nodes with size >10mm were more frequently seen with peritoneal carcinomatosis 
(84%) than in TB peritonitis which had more lymph nodes with size < 10mm (57.1%) 
(27). 
Peritoneal carcinomatosis and pseudomyxoma peritonei arise from either primary or 
secondary peritoneal cancer and are treated by cytoreductive surgery which primarily 
comprises of removal of all macroscopic disease. The suitability for the complete 
resection is determined by preoperative imaging commonly using a scoring system 
designed to estimate the extent of peritoneal carcinomatosis called the peritoneal cancer 
index (PCI). 
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K Flicek et al in 2015 conducted a study to assess the correlation of tumor burden 
assessment as estimated by the radiologic PCI with actual surgical PCI. They included 
a total of 42 patients who underwent cytoreductive surgery for either PC or PMP. They 
used a standardized template to assess different locations in the abdomen and the tumor 
amount present in those locations to generate a radiologic PCI. The radiologic PCI thus 
obtained was compared with surgical PCI as the gold standard. The radiologic PCI score 
had a sensitivity, specificity, positive and a negative predictive value of 76% (22/29), 
69% (9/13), 85% (22/26) and 56% (9/16) respectively as compared to surgical PCI. 
Overall, the radiological and surgical scoring was similar in 31/42 (74%) of patients 
(28).  
D. Diaz-Gil et al conducted a study in 2016 to assess the correlation of PCI obtained by 
CT with serum levels of tumor marker CA-125 and 5-year survival in advanced stage 
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ovarian cancer patients. They evaluated CT-PCI of 82 patients with stage III or stage 
IV ovarian cancer using Sugarbaker classification prior to the cytoreductive surgery. 
Using linear regression analysis, they found that there was significant co-relation (r = 
0.487, P < 0.001) between the pre-surgical CT-PCI and the pre-surgical CA-125 serum 
levels. Using multivariate binary logistic regression, significant improvement in 5-year 
survival was noted with lower CT- PCI and Eastern Cooperative Oncology Group 
(ECOG) score (29).   
A. Dohan et al in 2017 conducted a study to evaluate the added value of MRI in 
combination with CT as compared to CT alone in patients with peritoneal metastases, 
evaluating a total of 28 patients. CT-PCI was determined first from the analysis of CT 
images alone by two observers, MRI examinations in combination with CT was then 
analyzed by the two observers to determine a second set of PCI values. Using surgical 
PCI as reference, the sensitivity and negative predictive values of the two imaging sets 
were then estimated. They found that CT in combination with MRI was more accurate 
in preoperative estimation of PCI compared with CT alone. The absolute difference in 
the PCI values compared to the surgical PCI obtained by using CT alone was more than 
in combination with MRI (mean (s.d.) 4⋅89(4⋅73) versus 3⋅96(4⋅10); P = 0⋅010). The 
number of true-positive findings and sensitivity (from 63 to 81 per cent for reader 1; 
from 44 to 81 per cent for reader 2) increased for both the observers with the added use 
of MRI examinations. The increase in sensitivity was found to be more for patients with 
a moderate volume of disease (30).  
Employing a multimodality approach with a clear understanding of the clinical and 
pathophysiology of each disease in co-relation with the patient’s history, the radiologist 
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can improve the diagnostic yield of these diseases (3). We in our current study, plan to 
assess the diagnostic accuracy of CT in differentiating the etiology of diffuse peritoneal 
disease with histopathology co-relation and to develop a CT algorithm to aid diagnosis 
and management.  
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MATERIALS AND METHODS 
 
TYPE OF STUDY: Retrospective observational study for assessing diagnostic accuracy 
Scheme of research: 
All patients with peritoneal disease who had contrast enhanced CT imaging and 
subsequently underwent omental biopsies (both surgical and ultrasound guided) were 
included in our study. All such patients who had their omental biopsies from 1st January 
2016 to 31st December 2017 were included in this study. The imaging findings were 
reviewed in PACS by 2 radiologists independently, who were blinded to the patient 
demographics, the clinical findings and the histopathologic results. The CT findings 
were assessed under various specific headings, predominantly so as to describe 
peritoneal, mesenteric or omental involvement like thickening, enhancement, 
nodularity etc. and also general features like ascites, lymphadenopathy and 
splenomegaly. The histopathology reports were then finally assessed and the variables 
on CT were evaluated with histopathology as the gold standard. 
 
Sample size calculation:  
Our pilot study of three months duration for CT correlation with HPE, showed the following 
findings:  
                              - 25 out of 34 –had concurrent diagnosis (both CT and HPE) 
                              - 4 out of 34 –had discordant diagnosis    
                              - 5 out of 34 –had equivocal findings (no definite CT diagnosis) 
This analysis suggested a sensitivity of ~ 73 %. Previous studies have a shown a sensitivity of 
75%. 
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Overall, considering a sensitivity of 70% for the purpose of sample size calculation  
With 10% precision and 95% confidence interval using the following formula:  
n = (4*p*q) / (d*d): p-sensitivity=70%, q=1-p, d=10% 
A minimum sample of 84 subjects was calculated. We included a total of 136 patients 
in our study.  
 
Inclusion criteria: 
- All patients with peritoneal disease who had CT examinations in our 
department and subsequently underwent omental biopsies (both surgical and 
ultrasound guided).  
Exclusion criteria: 
- Patients with no contrast enhanced CT examination of the abdomen and 
pelvis   
- Inconclusive biopsy results 
- Patients with known malignancy / obvious primary malignancy on CT  
Index or experimental test: Contrast enhanced CT examination of the abdomen and pelvis 
was the experimental test (CECT) 
Evaluators:  
1) First observer: Combined analysis done by a radiologist with 4 years’ experience along 
with another radiologist with 7 years’ experience. 
2) Second observer: Radiologist with 16 years’ experience. 
Minimizing bias: 
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The index test was interpreted independently of the reference standard and without 
knowledge of the results. 
Knowing the histopathological diagnosis prior to or during the assessment of the CT 
findings is a definite source of bias. The reporting radiologists were blinded to the 
patient demographics as well as to the clinical findings and the histopathologic results 
during the image interpretation until the assessment of CT findings of all the recruited 
patients was completed and were ready for correlation with HPE reports. 
Informed Consent: 
As the study was a retrospective analysis and did not involve any direct patient interaction 
(we were blinded to patient demographics and clinical history) and no additional 
investigations were conducted on the patients, the requirement for an informed consent was 
waived.  
Statistical methods:  
 
Data were summarized using mean(SD)/ median(IQR) for continuous variables and 
categorical variables were expressed as frequency and percentage. The baseline 
continuous variables were compared between the benign and malignant using 
independent-t-test, and the categorical variables were compared using chi-
square statistics. The significant predictors at 5% level were chosen and a logistic 
regression was performed mutually adjusted for the predictors selected. The estimate of 
effect size was given as Odds ratio with 95% CI. The diagnostic accuracy of radiology 
with histology results were presented with 95%CI.  All the statistical analysis were 
performed using STATA/ IC 15.0 
 31 
RESULTS AND ANALYSIS 
 
Total patients evaluated: 136 
Baseline patient characteristics:  
 
1. Age distribution  
The mean age of patients included in our study was 44 +/- 16.3 years with an age 
range of 10 to 88 years.  
 Benign Malignant OR (95% CI) P- Value  
Age 34.9  +/-  14.1 53.75  +/- 12.6 1.10 (1.06,1.14) <0.001 
 
- Higher age had a statistically significant positive association with malignant 
etiology with an odds ratio of 1.1 (95%CI,1.06-1.14) and a p-value of <0.001.  
2. Gender distribution  
- 40.4 % (n = 55) of our patients were men while 59.5% (n = 81) were women.  
- Among the patients with benign etiology, 47.2 % (n = 34) were men, while 
52.8% (n = 38) were women.  
- Among the patients with malignant etiology, 32.8% (n = 21) were men, while 
67.2% (n = 43) were women. 
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Sex Benign Malignant OR (95% CI) P- Value  
Male  34 (47.2) 21 (32.8) 0.54 (0.27, 1.09) 0.087 
Female 38 (52.8) 43 (67.2)  
 
- There was no gender predilection for benign or malignant etiology of the 
peritoneal disease.  
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CT findings  
 
a. Peritoneum  
Peritoneum was thickened in 95.59 % (130) of the patients. 
- Among the 64 patients with malignant etiology, peritoneal thickening was 
present in 61 patients (95.3%). 
- Among the 72 patients with benign etiology, peritoneal thickening was present 
in 69 patients (95.8%). 
 
 
Peritoneal 
thickening 
Malignant Benign OR (95% CI) P- Value  
Present  61 (95.3) 69 (95.8) 0.88 (0.17, 4.54) 0.882 
Absent  3 (4.6) 3 (4.1)  
 
- Presence of peritoneal thickening did not have any bearing on whether the 
etiology was benign or malignant. 
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- The mean thickness of peritoneum was 6.78 mm with a minimum of 1 mm and 
a maximum of 85 mm. The standard deviation was 9.65 mm. 
 Benign Malignant OR (95% CI) P- Value  
Peritoneal 
thickness (mm) 
5.11 +/- 5.79 8.67 +/- 12.45 1.06 (0.99,1.14) 0.071 
 
- The thickness of peritoneum did not contribute to differentiating malignant from 
benign etiology.  
• Peritoneal thickening was irregular in 69.2% (n = 90) of patients and smooth in 
30.8 % (n = 40) of the patients. 
 
 
- Among the 61 patients with malignant etiology and peritoneal thickening, the 
peritoneal thickening was smooth in 24.6% (n = 15) patients and irregular in 
75.4% (n = 46) patients.  
- Among 69 patients with benign etiology, peritoneal thickening was smooth in 
36.2% (n = 25) patients while it was irregular in 63.8% (n = 44) patients. 
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Type of thickening Malignant Benign OR (95% CI) P- Value  
Irregular 46 (75.41) 44 (63.77) 1.74 (0.81, 3.8) 0.151 
 
 
Smooth 15 (24.59) 25 (36.23)  
 
- The type of peritoneal thickening, whether it was smooth or irregular did not 
contribute to differentiating malignant from benign etiology  
• Peritoneal nodules were seen in 26.5 % (n = 36) of the patients while 73.5% (n 
= 100) of the patients did not have peritoneal nodules  
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- Of the 64 patients with malignant etiology, peritoneal nodules were present in 
31.25% (n = 20) patients while 68.75% (n = 44) patients had no peritoneal 
nodules. 
- Of the 72 patients with benign etiology, peritoneal nodules were present in 
22.2% (n = 16) while 77.8% (n = 56) patients had no peritoneal nodules. 
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Peritoneal 
nodules  
Malignant Benign OR (95% CI) P- Value  
Present  20 (31.25) 16 (22.2) 1.59 (0.73, 3.42) 0.233 
Absent 44 (68.75) 56 77.8)  
 
- The presence of peritoneal nodules did not contribute in differentiating 
malignant from benign etiology.  
• Out of the 36 patients with peritoneal nodules, 55.6% (n = 20) patients had 
nodules of sizes < 10 mm while 44.4% (n = 16) had nodules of size > 10 mm 
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- Among the 20 patients with peritoneal nodules who had malignant etiology, 
40% (n = 8) had nodules with sizes less than 10 mm, while 60% (n = 12) had 
sizes more than 10 mm. 
- Among the 16 patients with peritoneal nodules who had benign etiology, 25% 
(n = 4) had nodules with sizes more than 10 mm while 75% (n = 12) had less 
than 10 mm. 
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Size of p. nodules Malignant Benign OR (95% CI) P- Value  
>10 mm 12 (60) 4 (25) 4.5 (1.06, 19. 04) 0.035 
 < 10 mm 8 (40) 12 (75)  
 
- The size of peritoneal nodules >10 mm had a statistically significant association 
(p = 0.035) with malignant etiology. 
• Of the 36 patients with peritoneal nodules, 16.7% (n = 6) patients had less than 
5 nodules, while 83.3% (n = 30) had more than 5 nodules. 
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- Among 20 patients with peritoneal nodules who had malignant etiology, 15% 
(n = 3) had peritoneal nodules less than 5 in number, while 85% (n = 17) had 
more than 5 peritoneal nodules  
- Among the 16 patients with peritoneal nodules who had benign etiology, 81.3% 
(n = 13) had more than 5 while 18.7% (n = 3) had less than 5.  
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Number of p. 
nodules 
Malignant  Benign OR (95% CI) P- Value  
>5 17 (85) 13 (81.25) 1.30 (0.22, 7.56) 0.764 
<5 3 (15) 3 (18.75)  
 
- The number of peritoneal nodules (>5/< 5) was not useful in differentiating 
malignant from benign etiology of peritoneal disease (p = 0.764). 
• Of the 36 patients with peritoneal nodules, 91.7% (n = 33) of the peritoneal 
nodules were predominantly-solid, 2.8 % (n = 1) was predominantly-cystic while 
5.6% (n = 2) were of mixed density.  
 
- Among the 20 patients with peritoneal nodules who had malignant etiology, 
85% (n = 17) were of predominantly-solid density, 5% (1) of predominantly-
cystic density while 10% (n = 2) were of mixed density  
- The density of peritoneal nodules in all the 16 patients who had benign etiology 
was predominantly-solid.  
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- Calcification was not seen in any of the peritoneal nodules.  
- Peritoneal cyst was seen in only 1 patient and who had malignant etiology. 
- Scalloping was seen in 16.2% (n = 22) of the patients while 83.8% (n = 114) of 
the patients had no scalloping. 
- Of the 64 patients with malignant etiology, 26.5% (n = 17) patients had 
scalloping, while 73.4% (n = 47) had no scalloping. 
- Of the 72 patients with benign etiology, 6.9% (n = 5) had scalloping while 
93.1% (n = 67) had no scalloping  
75%
80%
85%
90%
95%
100%
Malignant Benign
85
1005
0
10
Nodule density
Predominantly solid Predominantly cystic Mixed
 43 
 
 
 
Scalloping 
peritoneum 
Malignant Benign OR (95% CI) P- Value  
Present 17 (26.56) 5 (6.94) 4.84 (1.67, 14.05) 0.001 
Absent 47 (73.44) 67 (93.06)  
 
- The presence of scalloping had a statistically significant (p = 0.001) positive 
association with malignant etiology.   
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b. Omentum  
- Thickened in all the 136 patients  
- The mean thickness of omentum was 22.85 mm with a minimum of 4 mm and 
a maximum of 50 mm. The standard deviation was 8.85 mm. 
 Benign Malignant OR (95% CI) P- Value  
Omental thickness 
(mm) 
20.69 +/- 6.96 25.28 +/- 10.09 1.06 (1.02,1.11) 0.004 
 
 
- The thickness of omentum had a statistically significant (p = 0.004) positive 
association with malignant etiology.  
 
 
 
 
• Omental stranding was seen in 99.26% (135) of the patients.  
- Among the patients with malignant etiology, omental stranding was seen in 
98.4% (n = 63) patients while 1.6% (n = 1) patient did not have omental 
stranding  
- All the 72 patients with benign etiology had omental stranding 
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• Omental mass / caking was seen in 33.8% (n = 46) of the total 136 patients, while 
66.2 % (n = 90) had no omental mass / caking 
 
 
 
- Of the 64 patients with malignant etiology, 53.1% (n = 34) had omental 
mass/caking, while 46.9% (n = 30) did not 
- Of the 72 patients with benign etiology, 16.6% (n = 12) patients had omental 
mass/caking, while 83.3% (n = 60) did not. 
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Omental mass / 
Caking 
Malignant Benign OR (95% CI) P- Value  
Present 34 (53.13) 12 (16.67) 5.66 (2.57, 12.4) 0.000 
Absent 30 (46.88) 60 (83.33)  
 
- The presence of omental mass/caking had a statistically significant (p = 0.000) 
positive association with malignant etiology.  
•  Omental nodules were seen 35.3% (n = 48) patients, while 64.7% (n = 88) did 
not have any omental nodules.  
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- Of the 64 patients with malignant etiology, 37.5% (n = 24) had omental nodules 
while 62.5% (n = 40) did not. 
- Of the 72 patients with benign etiology, 33.3% (n = 24) had omental nodules 
while 66.7% (n = 48) did not. 
 
Omental nodules Malignant Benign OR (95% CI) P- Value  
Present 24 (37.5) 24 (33.33) 1.2 (0.59, 2.42) 0.611 
Absent 40 (62.5) 48 (66.67)  
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- The presence of omental nodules did not contribute to differentiating malignant 
from benign etiology. 
• Of the 48 patients with omental nodules, the size of the omental nodules was > 
10 mm in 25% (n = 12) of the patient while 75% (n = 36) of the patients had 
nodules of size < 10 mm.  
 
- Among the 24 patients with malignant etiology, 75% (n = 18) had omental 
nodules with size <10 mm, 25% (n = 6) had sizes >10 mm  
- Among the 24 patients with benign etiology, 75% (n = 18) had omental nodules 
with size <10 mm, 25% (n = 6) had sizes >10 mm.  
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Omental Nodule size Malignant Benign OR (95% CI) P- Value  
< 10 mm 18 (75) 18 (75) 1 (0.27, 3.69) >0.99 
>10 mm 6 (25) 6(25)  
 
- The size of omental nodules did not contribute to differentiating malignant from 
benign etiology.  
• Out of the 24 patients with malignant etiology, 95.8% (n = 23) patients had 
omental nodules more than 5 in number, while 4.2 % (n = 1) patient had less 
than 5 nodules 
- Similarly, among those with benign etiology, 95.8% (n = 23) patients had 
omental nodules more than 5 in number, while 4.2% (n = 1) patient had less 
than 5 nodules 
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- The number of omental nodules did not contribute to differentiating malignant 
from benign etiology.  
• The density of the omental nodules was predominantly-solid in 97.9% (n = 47) 
and mixed in 2.1% (n = 1) of the patients.  
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- Among the 24 patients with malignant etiology, the density of the peritoneal 
nodules was predominantly-solid in 95.8% (n = 23) patients, while 4.2% (n = 1) 
patient had mixed density  
- All 24 patients with benign etiology had omental nodules of predominantly-
solid density. 
• Both benign and malignant etiology patients had one patient each with omental 
nodule calcification. 
 
c. Mesentery  
- Thickening and stranding of mesentery was seen in 85.3% (n = 116) of the 
patients, while 14.7% (n = 20) did not have these findings.  
 
- Of the 64 patients with malignant etiology, 78.1% (n = 50) had thickening and 
stranding of mesentery while 21.9% (n = 14) did not have. 
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- Of the 72 patients with benign etiology 91.7% (n = 66) had mesenteric stranding 
/ thickening while 8.3% (n = 6) did not have. 
 
 
 
Mesenteric 
thickening/ stranding 
Benign Malignant OR (95% CI) P- Value  
Present 66 (91.67) 50 (78.13) 3.08 (1.1, 8.5) 0.026 
Absent 6 (8.33) 14 (21.88)  
 
- The presence of mesenteric thickening/stranding had a statistically significant 
(p = 0.026) association with benign etiology.  
- Mesenteric mass was seen in only 2.2% (n = 3) of the 136 patients. All three 
were of malignant etiology.  
- Mesenteric nodules were seen in 9.6% (n = 13) while 90.4% (n = 123) had no 
mesenteric nodules. 
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- Of the 64 patients with malignant etiology, 7.8% (n = 5) had mesenteric nodules 
while 92.2% (n = 59) did not.  
- Of the 72 patients with benign etiology, 11.1% (n = 8) had mesenteric nodules 
while 88.9% (n = 64) did not.   
 
Mesenteric nodules Malignant Benign OR (95% CI) P- Value  
Present 5 (7.81) 8 (11.11) 0.67 (0.20, 2.18) 0.513 
Absent 59 (92.19) 64 88.89)  
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- The presence of mesenteric nodules did not contribute to differentiating 
malignant from benign etiology. 
• Of the 5 patients with malignant etiology, 20% (n = 1) had mesenteric nodules 
of sizes less than 10 mm while 80% (n = 4) were of sizes more than 10mm. 
- Among the 8 patients with benign etiology, 87.5% (n = 7) had nodules of sizes 
less than 10mm, while 12.5% (n = 1) had nodules of sizes more than 10 mm  
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Size of mesentery 
nodules  
Malignant Benign OR (95% CI) P- Value  
>10mm 4 (80) 1 (12.5) 28 (1.3, 580.6) 0.014 
<10 mm 1 (20) 7 (87.5)  
 
- The presence of mesenteric nodules of sizes >10 mm had a statistically 
significant (p = 0.014) positive association with malignant etiology.   
- The number of nodules were less than 5 in 7.7% (n = 1) while 92.3% (n = 12) 
patient had more than 5 nodules.  
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- Of the 5 patients with malignant etiology, 80% (n = 4) had mesenteric nodules 
more than 5, while 20% (n = 1) had nodules less than 5 in number  
- All the 8 patients with benign etiology had more than 5 nodules  
- The mesenteric nodules did not show any calcification 
d) Serosal involvement  
- Serosal involvement was seen in 43.4% (n = 59) of the patients, while 56.6% (n 
= 77) did not show any serosal involvement  
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- Among the 64 cases who had malignant etiology, 56.2% (n = 36) had serosal 
involvement while 43.7% (n = 28) had none 
- Among the 72 who had benign etiology, 31.9% (n = 23) had serosal implants 
while 68.1% (n = 49) had none  
 
Serosal involvement Malignant Benign OR (95% CI) P- Value  
Present 36 (56.25) 23 (31.94) 2.73 (1.36, 5.51) 0.0043 
Absent 28 (43.75) 49 (68.06)  
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- Serosal involvement had a statistically significant (p = 0.004) positive 
association with malignant etiology.  
e) Liver involvement  
- Liver was enlarged in 47.8% (n = 65) of the patients, while 52.2% (n = 71) had 
normal size of the liver.  
 
- Among the 64 cases who had malignant etiology, 42.2% (n = 27) patients had 
hepatomegaly while 57.8% (n = 37) did not.  
- Among the 72 patients who had benign etiology, 52.8% (n = 38) patients had 
hepatomegaly while 47.2% (n = 34) did not.  
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Hepatomegaly Malignant Benign OR (95% CI) P- Value  
Present 27 (42.19) 38 (52.78) 0.65 (0.33, 1.28) 0.217 
Absent 37 (57.81) 34 (47.22)  
 
- The presence of hepatomegaly did not contribute to differentiating malignant 
from benign etiology.  
- Focal liver lesions were seen in 20.6% (n = 28) of the patients, while 79.4% (n 
= 108) had no focal liver lesions.  
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- Among the 64 cases who had malignant etiology, focal liver lesions were seen 
in 20.3% (n = 13) patients while 79.7% (n = 51) patients did not.  
- Among the 72 patients who had benign etiology, 20.8% (n = 15) patients had 
focal liver lesions while 79.2% (n = 57) patients did not have any  
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Focal lesions in 
liver 
Malignant Benign OR (95% CI) P- Value  
Present 13 (20.31) 15 (20.83) 0.96 (0.42, 2.22) 0.940 
Absent 51 (79.69) 57 (79.17)  
 
- The presence of focal liver lesions did not contribute to differentiating 
malignant from benign etiology.  
- Of the 64 patients with malignant etiology, only 1 patient had IHBRD  
- None of the patients with benign etiology had IHBRD  
f) Splenic involvement  
- Spleen was enlarged in 11.03% (n = 15) of the patients while 88.97% (n = 121) 
had no splenomegaly.  
- Of the 64 patients with malignant etiology, 1.6% (n = 1) patient had 
splenomegaly while 98.4% (n = 63) patients did not  
- Among the 72 patients with benign etiology, splenomegaly was seen in 19.4% 
(n = 14) patients while 80.6% (n = 58) did not. 
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Splenomegaly Benign Malignant OR (95% CI) P- Value  
Present 14 (19.44) 1 (1.56) 15.20 (1.9, 119.3) <0.001 
Absent 58 (80.56) 63 98.44)  
 
- Presence of splenomegaly had a statistically significant (p = <0.001) positive 
association with benign etiology.  
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• Focal lesions in spleen were seen in 5.15% (n = 7) of the patients, while 94.8% 
(n = 129) had no focal splenic lesions.  
- Of the 64 patients with malignant etiology, 4.7% (n = 3) patients had focal 
lesions in the spleen while 95.3% (n = 61) patients did not.  
- Among the 72 patients with benign etiology, 5.6% (n = 4) patients had focal 
splenic lesions while 94.4 (n = 68) patients did not.  
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Focal splenic lesions Malignant Benign OR (95% CI) P- Value  
Present 3(4.69) 4 (5.56) 0.83 (0.17, 3.88) 0.819 
Absent 61(95.31) 68 (94.44)  
 
- Presence of focal splenic lesions did not contribute to differentiating malignant 
from benign etiology. 
g) Lymphadenopathy 
- Enlarged lymph nodes were seen in 71.3% (n = 97) of the patients while 28.7% 
(n = 39) had no lymphadenopathy.  
- Of the 64 patients with malignant etiology, 64.0% (n = 41) patients had 
lymphadenopathy while 35.9% (n = 23) patients did not  
- Of the 72 patients with benign etiology, 77.8% (n = 56) patients had 
lymphadenopathy, while 22.2% (n = 16) patients did not  
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Lymphadenopathy Malignant Benign OR (95% CI) P- Value  
Present 41 (64.06) 56 (77.78) 0.50 (0.23, 1.08) 0.077 
Absent 23 (35.94) 16 (22.22)  
 
There was no significant difference in the presence or absence of 
lymphadenopathy between benign and malignant etiologies of peritoneal 
disease.  
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• Diaphragmatic nodes  
- Of the 41 patients with lymphadenopathy who had malignant etiology, 51.2% 
(n = 21) had significant diaphragmatic adenopathy while 48.8% (n = 20) did 
not.  
- Of the 56 with benign etiology, 64.3% (n = 36) had significant diaphragmatic 
adenopathy while 35.7% (n = 20) did not 
Diaphragmatic adenopathy  Malignant  Benign OR (95%CI) P- value 
Present  21 (51.22)  36 (64.29)  0.58(0.25, 1.3) 0.19 
Absent 20 (48.78)  20 35.71)    
 
The presence of diaphragmatic lymphadenopathy did not contribute in 
differentiating malignant from benign etiology.  
• Mediastinal adenopathy  
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- Of the 41 patients with lymphadenopathy who had malignant etiology, 26.8% 
(n = 11) had significant mediastinal adenopathy while 73.1% (n = 30) did not.  
- Of the 56 with benign etiology, 33.9% (n = 19) had significant mediastinal 
adenopathy while 66.1% (n = 37) did not. 
Mediastinal adenopathy Malignant  Benign OR (95%CI) P- value 
Present  11 (26.83) 19 (33.93) 0.71(0.29,1.73) 0.45 
Absent 30 (73.17) 37 (66.07)    
 
The presence of mediastinal lymphadenopathy did not contribute in 
differentiating malignant from benign etiology.  
• Lesser omental adenopathy   
- Of the 41 patients with lymphadenopathy who had malignant etiology, 39.02% 
(n = 16) had significant lesser omental adenopathy while 60.98% (n = 25) did 
not.  
- Of the 56 with benign etiology, 41.1% (n = 23) had significant lesser omental 
adenopathy while 58.9% (n = 33) did not. 
Lesser omental adenopathy  Malignant  Benign OR (95%CI) P- value 
Present  16 (39.02)  23 (41.07)  0.91(0.4, 2.0) 0.839 
Absent 25 (60.98)  33 (58.93)    
 
The presence of lesser omental lymphadenopathy did not contribute in 
differentiating malignant from benign etiology.  
• Greater omental adenopathy   
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- Of the 41 patients with lymphadenopathy who had malignant etiology, 2.4% (1) 
had significant greater omental adenopathy while 97.6% (n = 40) did not.  
- Of the 56 with benign etiology, 7.1% (n = 4) had significant greater omental 
adenopathy while 92.9% (n = 52) did not. 
Greater omental adenopathy Malignant  Benign OR (95%CI) P- value 
Present  1 (2.44) 4 (7.14)  0.32(0.03,3.02) 0.323 
Absent 40 (97.56)  52 92.86)    
 
The presence of greater omental lymphadenopathy did not contribute in 
differentiating malignant from benign etiology.  
• Mesenteric adenopathy   
- Of the 41 patients with lymphadenopathy who had malignant etiology, 17.1% 
(n = 7) had significant mesenteric adenopathy while 82.9% (n = 34) did not.  
- Of the 56 with benign etiology, 53.6% (n = 30) had significant mesenteric 
adenopathy while 46.4% (n = 26) did not. 
Mesenteric 
adenopathy 
Benign Malignant OR (95%CI) P- value 
Present  30 (53.57) 7 (17.07) 5.60(2.12,14.75) 0.0005 
Absent 26 (46.43) 34 (82.93)   
 
The presence of mesenteric lymphadenopathy had a statistically significant (p = 
0.0005) association with benign etiology.  
• Para-aortic adenopathy  
 69 
- Of the 41 patients with lymphadenopathy who had malignant etiology, 34.15% 
(n = 14) had significant para-aortic adenopathy while 65.85% (n = 27) did not.  
- Of the 56 with benign etiology, 44.6% (n = 25) had significant para-aortic 
adenopathy while 55.4% (n = 31) did not. 
Para-aortic adenopathy Malignant  Benign OR (95%CI) P- value 
Present  14 (34.15) 25 (44.64) 0.64(0.27,1.47) 0.298 
Absent 27 (65.85) 31 55.36)   
 
The presence of para-aortic lymphadenopathy did not contribute in 
differentiating malignant from benign etiology.  
• Para-iliac adenopathy  
- Of the 41 patients with lymphadenopathy who had malignant etiology, 7.3% (n 
= 3) had significant para-iliac adenopathy while 92.7% (n = 38) did not.  
- Of the 56 with benign etiology, 3.6% (n = 2) had significant para-iliac 
adenopathy while 96.4% (n = 54) did not. 
Para-iliac adenopathy Malignant  Benign OR (95%CI) P- value 
Present  3 (7.32) 2 (3.57) 2.09(0.33,13.13) 0.431 
Absent 38 (92.68) 53 96.43)   
 
The presence of para-iliac lymphadenopathy did not contribute in differentiating 
malignant from benign etiology.  
h) Necrotic lymph nodes 
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Necrotic lymph nodes were seen in 21.65% (n = 21) of the 97 patients with 
lymphadenopathy while 78.35% (n = 76) patients did not have necrotic lymph 
nodes  
 
- Of the 41 patients with lymphadenopathy who had malignant etiology, 9.8% (n 
= 4) had necrotic lymph nodes while 90.2% (n = 37) did not. 
 
- Of the 56 patients with lymphadenopathy who had benign etiology, 30.4% (n = 
17) patients had necrotic lymph nodes, while 69.6% (n = 39) did not.  
 
 
Necrotic lymph nodes Benign Malignant OR (95% CI) P- Value  
Present 17 (30.36) 4 (9.76) 04.03(1.2,13.1) 0.020 
Absent 39 (69.64) 37 (90.24)  
 
- The presence of necrotic lymph nodes had a statistically significant (p = 0.020) 
positive association with benign etiology.  
i) Ovarian involvement  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Malignant Benign
9.76
30.36
90.24
69.64
Necrotic lymph nodes
Present Absent
 71 
- Was seen in 60.5% (n = 49) of the 81 patients, while 39.5% (n = 32) did not 
have any ovarian involvement.  
- Among the 43 patients with malignant etiology, 65.1% (n = 28) had ovarian 
involvement while 34.9 (n = 15) had no ovarian involvement 
- Among the 38 patients with benign etiology, 55.3% (n = 21) had ovarian 
involvement, while 44.7 (n = 17) had none.   
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Ovarian 
involvement 
Malignant Benign OR (95% CI) P- Value  
Present 28 (65.12) 21 (55.26) 1.51 (0.61, 3.70) 0.365 
Absent 15 (34.88) 17 (44.74)  
 
The presence of ovarian involvement did not contribute in differentiating 
malignant from benign etiology.  
j) Bowel obstruction  
- Of the 72 patients with benign etiology, 2.8% (n = 2) had bowel obstruction, 
while 97.2% (n = 70) did not. 
- Of the 64 patients with malignant etiology, 4.7% (n = 3) had bowel obstruction, 
while 95.3% (n = 61) did not.  
Bowel obstruction Malignant Benign OR (95% CI) P- Value  
Present 3 (4.69) 2 (2.78) 1.72 (0.27, 10.64) 0.554 
Absent 61 (95.31) 70 97.22)  
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The presence of bowel obstruction did not contribute in differentiating malignant 
from benign etiology.  
k) Terminal ileum or cecal thickening  
- Was seen in 7.35% (n = 10) of the total 136 patients 
- Among the 64 patients with malignant etiology, 9.4% (n = 6) had terminal ileum 
/ cecal thickening while 90.6% (n = 58) had none. 
- Of the 72 patients with benign etiology, 5.6% (n = 4) had terminal ileum / cecal 
thickening while 94.4% (n = 68) did not.  
Terminal ileum or 
cecal thickening 
Malignant Benign OR (95% CI) P- Value  
Present 6 (9.38) 4 (5.56) 1.75 (0.47, 6.53) 0.394 
Absent 58 (90.63) 68 (94.44)  
 
The presence of thickening of terminal ileum/cecum did not contribute in 
differentiating malignant from benign etiology.  
l) Ascites   
- Was seen in 92.65% (n = 126) patients, while 7.35% (n = 10) had no ascites.  
- Of the 64 patients with malignant etiology, 92.2% (n = 59) had ascites while 
7.8% (n = 5) did not.  
- Of the 72 patients with benign etiology, 93.1% (n = 67) had ascites while 6.9% 
(n = 5) did not.  
 74 
 
Ascites Malignant Benign OR (95% CI) P- Value  
Present 59 (92.19) 67 (93.06) 0.88 (0.24, 3.19) 0.846 
Absent 5 (7.81) 4 (6.94)  
 
The presence of ascites did not contribute in differentiating malignant from 
benign etiology.  
• Ascites was loculated in 12.7% (n = 16) of the 126 patients and free in 87.3% (n 
= 110) of the patients.  
- Among the 59 patients with malignant etiology, 96.6% (n = 57) had free ascites 
while 3.4% (n = 2) had loculated ascites  
- Among the 67 patients with benign etiology, 79.1% (n = 53) had free ascites 
while 20.9% (n = 14) had loculated ascites.  
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Type of ascites Malignant Benign OR (95% CI) P- Value  
Free 57 (96.61) 53 (79.1) 7.52 (1.63, 34.69) 0.003 
Loculated  2 (3.39) 14 (20.9)  
 
The presence of free ascites had a statistically significant (p = 0.003) positive 
association with malignant etiology. 
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• Attenuation of the ascitic fluid was >20 HU in 50.8% (n = 64) while 49.2% (n = 
62) of the patients had HU <20.  
- Of the 59 patients with malignant etiology, ascitic fluid attenuation was >20 HU 
in 30.5% (n = 18) patients while 69.5% (n = 41) had < 20 HU. 
- Among the 67 patients with benign etiology, 68.7% (n = 46) had > 20 HU while 
31.3% (n = 21) patients had ascitic fluid attenuation < 20 HU. 
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Attenuation Benign Malignant OR (95% CI) P- Value  
>20 HU 46 (68.66) 18 (30.51) 4.98 (2.33, 10.64) 0.000 
< 20 HU 21 (31.34) 41 (69.49)  
 
- The presence of ascitic fluid with attenuation >20 HU had a statistically 
significant (p = 0.000) positive association with benign etiology. 
m) Pleural effusion 
- Was seen in 50.7% (n = 69) of 136 patients, while 49.3% (n = 67) of the patients 
had no pleural effusion. 
- Among the 64 patients with malignant etiology, 51.6% (n = 33) patients had 
pleural effusion while 48.4% (n = 31) patients did not. 
- Among the 72 patients with benign etiology, 50% (n = 36) patients had pleural 
effusion and an equal 50% (n = 36) did not.  
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Malignant Benign
30.51
68.66
69.49
31.34
Ascitic fluid attenuation
>20 HU < 20 HU
 78 
 
 
Pleural effusion Malignant Benign OR (95% CI) P- Value  
Present 33 (51.56) 36 (50) 1.06(0.54,2.08) 0.855 
Absent 31 (48.43) 36 (50)  
 
The presence of pleural effusion did not contribute in differentiating malignant 
from benign etiology.  
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• Pleural effusion was bilateral in 37.68% (n = 26) of the patients and unilateral in 
62.31% (n = 43) patients.  
- Among the 33 patients with malignant etiology, 51.5% (n = 17) had bilateral 
pleural effusion, while 48.5% (n = 16) had unilateral pleural effusion 
- Among the 36 patients with benign etiology, 25% (n = 9) patients had bilateral 
pleural effusion while 75% (n = 27) had unilateral pleural effusion. 
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Type of pleural 
effusion 
Malignant Benign OR (95% CI) P- Value  
Bilateral 17 (51.51) 9 (25) 3.18(1.15,8.81) 0.025 
Unilateral 16 (48.48) 27 (75)  
 
- The presence of bilateral pleural effusion had a statistically positive (p = 0.025) 
association with malignant etiology. 
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In summary, the following findings were most useful in CT differentiation of benign 
and malignant etiologies of diffuse peritoneal diseases:   
 
Features Benign 
 (n=72)  
Malignant  
(n=64) 
p value 
Age (years) 34.9  14.1   53.75  12.6  <0.001 
Size of peritoneal nodules 
(>10mm)  
4 (25%) 12 (60%) 0.035 
Visceral scalloping 5 (6.9%) 17 (26.6%) 0.001 
Omental thickness (mm) 20.69   6.96  25.28  10.09 0.004 
Omental mass / caking 12 (16.67%) 34 (53.13%) <0.001 
Mesenteric thickening / 
stranding  
66 (91.67%) 50 (78.13%) 0.026 
Size of mesenteric 
nodules (>10 mm) 
1 (12.5%) 4 (80%) 0.014 
Serosal involvement 23 (31.94%) 36 (56.25%) 0.004 
Splenomegaly  14 (19.4%) 1(1.6%) <0.001 
Mesenteric adenopathy 30 (53.6%) 7 (17.07%) <0.001 
Necrotic lymph nodes 17 (30.36%) 4 (9.8%) 0.020 
Free ascites  53 (79.1) 57 (96.6%) 0.003 
Ascitic fluid attenuation 
>20 HU 
46 (68.66%) 18 (30.51%) <0.001 
Bilateral pleural effusion 9 (25%)  17 (51.51%) 0.025 
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Interobserver analysis assessment and diagnostic accuracy:  
 
• There was substantial interobserver agreement for overall CT prediction of 
benign or malignant etiology of diffuse peritoneal disease with a Kappa of 0.713 
and a standard error of 0.06. (Landis and Koch, 1977)(31) 
• The following table shows the diagnostic performance of CT prediction of 
etiology of diffuse peritoneal disease using the above described CT findings 
which were found to be statistically significant:  
 
 Observer 1 Observer 2 
Sensitivity (95%CI) 79.2 % (65.9 – 89.2%) 74.6% (61.6-85%) 
Specificity (95%CI) 79.4% (67.9 – 88.3%) 97.1% (89.9 – 99.6%) 
Positive predictive value 
(95%CI) 
75% (61.6 – 85.6%) 95.7% (85.2 – 99.5%) 
Negative predictive value  
(95%CI) 
83.1% (71.7 – 91.2%) 81.7% (71.6 – 89.4 %)   
Accuracy (95%CI) 79.3 % (71.0 – 86.2%) 86.7% (79.6- 92.1%)  
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Specific analysis of TB vs peritoneal carcinomatosis:  
 
 
The above findings were almost matching with the benign vs malignant analysis as the 
majority of these 2 categories included TB and peritoneal carcinomatosis. The presence 
Features TB (n=58) Peritoneal carcinomatosis 
(n=58) 
p value 
Age (years) 34.6   13.6   54.1   12.7  <0.001 
Visceral scalloping 4 (6.9%) 17 (29.3%) 0.003 
Omental thickness (mm) 21.5   7.2 25.4  10.4 0.025 
Omental mass / caking 11 (18.9%) 31 (53.4%) <0.001 
Mesenteric thickening / 
stranding  
54 (93.1%) 44 (75.8%) 0.016 
Size of mesenteric nodules 
(>10 mm) 
1 (14.3%) 4 (80%) 0.041 
Serosal involvement 22 (37.9%) 33 (56.9%) 0.042 
Splenomegaly  10 (17.24%) 1 (1.7%) 0.020 
Mesenteric adenopathy 27 (57.4%) 6 (15.3%) <0.001 
Necrotic lymph nodes 14 (29.8%) 4 (10.2%) 0.033 
Free ascites  43 (81.1%) 52 (96.3%) 0.025 
Ascitic fluid attenuation 
>20 HU 
36 (67.9%) 16 (29.6%) <0.001 
Bilateral pleural effusion 5 (17.2%) 14 (48.3%) 0.015 
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of peritoneal nodules with size > 10 mm did not contribute to differentiating between 
TB and peritoneal carcinomatosis.  
 
Multivariate analysis:  
Variables Odds Ratio (95% CI) Std. Error P value 
Peritoneal nodules with sizes  
> 10 mm 
5.06 (0.09 – 284) 10.40 0.43 
Visceral scalloping 7.03 (0.22 - 221) 12.38 0.26 
Mesenteric nodules 1.26 (0.02 - 69.5) 2.58 0.91 
Serosal involvement 5.88 (0.21 – 166) 10.02 0.29 
Mesenteric adenopathy 0.03 (0.001 - 0.8) 0.05 0.04 
Necrotic lymph nodes 0.48 (0.01 – 15.2) 0.84 0.68 
Attenuation of ascitic fluid 
>20 HU 
2.7 (10.11 – 67.5) 4.45 0.54 
 
The mutually adjusted regression reported an R2 of 51.82% and the only variable 
significant was mesenteric adenopathy and which favoured benign etiology. 
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DISCUSSION 
 
Differentiating the varying etiologies of peritoneal disease can be an arduous task even 
with the help of imaging guidance. Only few studies have been conducted to study the 
various findings on CT which could answer the million-dollar question, “Is it benign or 
malignant?”. Our study to assess the role of CT in evaluating diffuse peritoneal disease 
included a total of 136 patients. The most common benign etiology in our study was 
tuberculosis (58 patients), the rest being amyloidosis and few nonspecific inflammation 
(13 patients). The most common malignant etiology was metastatic adenocarcinoma 
(51 patients), the rest being malignant mesothelioma (3 patients), pseudomyxoma 
peritonei (6 patients), 2 patients with primary peritoneal carcinoma, 1 lymphoma and 1 
with malignant GIST. Since there were very small numbers of few diagnostic 
subgroups, we primarily assessed these patients on the basis of whether their final 
diagnosis was of malignant or benign etiology on histopathological evaluation. 
The mean age of our study population was 43.77 and we found a statistically significant 
(p = <0.001) association of older age (mean age of 53.75 years) with malignant etiology. 
This is similar to the study by A.C. O’Neill et al. in which peritoneal carcinomatosis 
was seen in an older cohort with a mean age of 67.4 years (25). 
Our study, which had 81 female patients and 55 males, did not find any gender 
predilection for benign or malignant etiology. 
The CT findings were assessed under the following headings: 
Peritoneum: 
The mean thickness of peritoneum in our study was 6.78 mm. Since there were no 
defined criteria for peritoneal thickening, we considered all patients with peritoneal 
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thickness of  2 mm as thickened peritoneum which constituted 95.5 % of our study 
patients. A slightly lower percentage peritoneal thickening, 72% was seen in the study 
by A.C. O’Neill et al. In another study, by Charoensak et al, the corresponding figure 
was even lower (50%) (27). We did not find any significant positive association of 
peritoneal thickness with malignant etiology. Irregular type of thickening which was 
seen in 69.23% of our patients did not have any significant positive association with 
malignant etiology either. This finding is in contrast to the study by Charoensak et al. 
in which they found a statistically significant association of irregular peritoneal 
thickening with peritoneal carcinomatosis.  
Peritoneal nodules were seen in 26.47 % of our patients, in contrast to the study by A.C. 
O’Neill et al. in which the incidence of peritoneal nodules was as high as 75%. There 
was no statistically significant positive association of the peritoneal nodules with 
malignant etiology. This finding is in sharp contrast to the study by Charoensak et al in 
which they found a statistically significant association of peritoneal nodules with 
malignant etiology.   
The presence of peritoneal nodules with sizes more than 10 mm, had a positive 
association with malignant etiology and was found to be statistically significant (p= 
0.035). This finding was in contrast to the study by Charoensak et al. in which the size 
of peritoneal nodules was not useful in differentiating benign from malignant etiology.  
The number and density of peritoneal nodules did not show any association with 
malignant etiology.  Peritoneal cysts were seen in only one patient and who had a 
malignant etiology.  
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Scalloping of the visceral organs, primarily the liver and the spleen, was seen in 16.18% 
of our study patients and had a statistically significant (p = 0.001) positive association 
with malignant etiology. This is in contrast to a previous study by Sharma et al. which 
did not find any conclusive difference between TB or peritoneal carcinomatosis in 
relation to the presence of  visceral scalloping (32).  
Omentum: 
 
The study by Charoensak et al, comparing TB with peritoneal carcinomatosis did not 
find any significant difference in omental abnormalities. In our study, omentum was 
thickened in all 136 (100%) patients with a mean thickness of 22.85 mm. This finding 
could be owing to the fact that our study population comprised of all patients who 
underwent omental biopsies, and thereby all of them invariably had omental thickening. 
There was a statistically significant positive association of omental thickness with 
malignant etiology with a mean thickness of 25.28mm.  This finding is very similar to 
the study by Ha et al. in which omental thickening was found to be more associated 
with peritoneal carcinomatosis than tuberculous peritonitis, with a mean thickness of 
26 mm (26). Omental stranding did not show any significant association with benign or 
malignant etiology.  
Omental mass/ caking, which was considered when the normal omental fat was found 
replaced by fibrosis /tumor, was seen in 33.82% of our patients and had a significant 
positive association with malignant etiology. This was very similar to the study by A.C. 
O’Neill et al, in which the incidence was 32% and by Charoensak et al. in which the 
incidence was 31.6%. 
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Omental nodules, seen in 35.29% of our patients did not have a significant positive 
association with malignant etiology, similar to the study by Charoensak et al, where the 
incidence was 31.6%. The size of the omental nodules was not useful to differentiate 
benign from malignant etiology, much in contrast to peritoneal nodules which had a 
positive size association with malignant etiology.  
There was no association of the number or the density or the presence of calcification 
within nodules with benign or malignant etiology.  
Mesentery:  
Thickening or stranding of mesentery which was seen in 85.29% of our patients showed 
a statistically significant (p = 0.026) positive association with benign etiology. This 
finding was similar to the study by Charoensak et al in which the incidence was 88.9% 
and a study by Ha et al in which the incidence was 98%. Both these studies showed a 
high association of mesenteric abnormalities with TB, found to be statistically 
significant.  
Contrastingly however, in a study by Shim et al., although mesenteric thickening was 
seen in 72.2% of patients with tuberculous peritonitis, this finding was not statistically 
significant (5).  
The presence or the number of mesenteric nodules did not show any significant 
association with malignant etiology.  
The incidence of mesenteric nodules with sizes >10 mm was 38.4% in our study, similar 
to the study by Charoensak et al. which had 33.3 % and Ha et al in which the incidence 
of mesenteric nodules with sizes > 5 mm was 24.4%. However, in contrast to these 
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studies, we found that mesenteric nodules with sizes >10mm had a high association 
with malignant etiology which was statistically significant (p = 0.014).   
Mesenteric masses were seen in only 3 patients, all of which were of malignant etiology 
and included metastatic adenocarcinoma, lymphoma and malignant mesothelioma.  
Serosal involvement: 
The involvement of serosa, in the form of thickening or presence of implants was seen 
in 43.38% of our patients and showed a statistically significant (p = 0.004) association 
with malignant etiology. This is similar to the incidence in the study by A.C. O’Neill et 
al, where an incidence of 37% was found among patients with malignant etiology (25).   
Hepatomegaly and focal liver lesions: 
There was no significant association of hepatomegaly with malignant etiology. 
Although not statistically significant, the incidence was higher in benign etiology. This 
finding could likely be attributed to hepatomegaly being more associated with TB. The 
presence of focal liver lesions did not show any association with either benign or 
malignant etiology. 
Splenic involvement: 
Splenomegaly, seen in 11.03% of our patients had a statistically significant positive 
association with benign etiology. This could be attributed to higher prevalence of 
splenomegaly among those with TB. This corroborates with the study by Ha et al where 
splenomegaly was seen in 92% of patients with tuberculous peritonitis compared to 
50% in peritoneal carcinomatosis.  
Focal lesions in the spleen however in contrast had no significant association with 
benign or malignant etiology in our study.  
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Lymphadenopathy: 
Lymph nodes of sizes greater than 10 mm in short axis dimension were considered as 
significant adenopathy with the exception of lesser omental nodes for which 6mm was 
taken as upper limit of normal and similarly, 15 mm for para-iliac lymph nodes. We did 
not find any significant association of intraabdominal lymphadenopathy with malignant 
or benign etiology.  This is in contrast to the study by Charoensak et al where they found 
that lymph nodes of sizes <10 mm were more frequently encountered in TB while those 
with sizes >10 mm were more common in peritoneal carcinomatosis.  
Mesenteric adenopathy, however, showed a statistically significant association with 
benign etiology while the rest of the individual lymph nodal stations did not show any 
association with either benign or malignant etiology.  
Necrotic lymph nodes, seen in 21.56% of our study patients showed a statistically 
significant positive association with benign etiology. This could be attributed to their 
higher prevalence in cases of TB which characteristically show necrotic nodes.  
Ovarian involvement: 
Presence of abnormal enhancement or enlargement of ovaries was considered as 
ovarian involvement. This was seen in 60.49% of the female patients. These had a 
positive association with malignant etiology, although not statistically significant. 
Bowel involvement:  
Involvement of bowel in the form of obstruction or thickening of terminal ileum or the 
cecum although had a higher incidence with malignant etiology, however, this was not 
statistically significant. This finding however is in contrast to the fact that thickening of 
terminal ileum /cecum is characteristically seen in cases of TB.  
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Ascites:  
Ascites, seen in 92.65% of our patients did not have any positive association with 
malignant etiology in itself. Free ascites without loculations had a statistically 
significant (p= 0.003) positive association with malignant etiology. This finding may 
be explained by the fact that loculated ascites is commonly associated with 
infective/inflammatory conditions. This is similar to the finding by Charoensak et al, 
where in addition they also found that loculated ascites was more frequently 
encountered with TB peritonitis than with peritoneal carcinomatosis. 
The attenuation of ascitic fluid more than 20HU has been proposed to be related to the 
exudative nature of the fluid in cases of infections (33). Our study corroborates this 
finding with a statistically significant association of ascitic fluid attenuation of >20 HU 
with benign etiology primarily including infective and inflammatory causes. 
Pleural effusion:  
There was positive association of pleural effusion with malignant etiology although not 
statistically significant. Bilateral pleural effusion was seen to have a statistically 
significant positive association with malignant etiology. 
TB vs Peritoneal carcinomatosis   
With the exception of size of peritoneal nodules, similar distribution of all the variables 
described above were also seen when differentiating between TB and peritoneal 
carcinomatosis. The presence of large peritoneal nodules >10 mm did not significantly 
contribute to differentiating TB from carcinomatosis. 
Multivariate analysis: 
Mesenteric adenopathy was the only variable which was significant, and favoured a 
benign etiology. 
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Interobserver analysis:  
We found good sensitivity and specificity of CT for differentiating between benign and 
malignant etiology of peritoneal disease with an accuracy of 79.3 % for observer 1 and 
86.7% for observer 2. A higher positive predictive value (95.7%) was noted for observer 
2, while for observer 1 the negative predictive value was higher (83.1%). There was 
also substantial interobserver agreement for overall CT prediction of benign or 
malignant etiology of diffuse peritoneal disease.  
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CONCLUSION and LIMITATIONS 
 
CONCLUSION 
Contrast enhanced CT was shown to have good sensitivity and specificity for 
differentiating benign and malignant etiologies of diffuse peritoneal disease.  
Higher age, increasing omental thickness, omental caking, larger mesenteric/peritoneal 
nodules, visceral scalloping, free ascites, serosal involvement and bilaterality of pleural 
effusion were the findings found to be significantly associated with malignant etiology.  
Findings such as mesenteric thickening/stranding, mesenteric adenopathy, necrotic 
lymph nodes, splenomegaly and higher attenuation (>20HU) of ascitic fluid were found 
to be significantly associated with benign etiology.  
With the exception of size of peritoneal nodules, the variables described above also held 
true for differentiating between TB and peritoneal carcinomatosis.  
Overall, we can conclude that CT has a high diagnostic accuracy for assessment of 
etiology of diffuse peritoneal disease. 
 
LIMITATIONS  
Our study had a few limitations. Firstly, it was a retrospective study. The clinical history 
and demographic features which were not assessed so as to prevent bias, also deprived 
us of valuable information which could point towards the final diagnosis in addition to 
the CT findings. The ability to pick up important CT findings depends to a large extent 
on the expertise of reading radiologist.  
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APPENDIX – 2 CLINICAL RESEARCH FORM (PROFORMA) 
 
 
S. No:             Age:  
 
Hospital ID:  
 
Sex:  
 
 
CT features: 
Findings  Yes No 
Peritoneum  Thickening 
 
            ----mm  
Smooth    
Irregular    
Nodule Size of 
the 
largest  
<10 mm   
>10 mm  
Number  <5  
>5  
Density  Predominantly Solid  
Predominantly 
Cystic 
 
Mixed  
Calcification Fine  
Coarse  
Scalloping    
Cysts  
Omentum  Thickening                      ….mm  
 
 
Mass / Caking    
Stranding    
Nodules  Size of 
the 
largest  
<10 mm   
>10 mm  
       
Male   Female   
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Number  <5  
>5  
Density  Predominantly Solid  
Predominantly 
Cystic 
 
Mixed 
Calcification Fine  
Coarse 
Mesentery   Thickening / Stranding   
Mass   
Nodules  Size of 
the 
largest  
<10 mm   
>10 mm 
Number  <5  
>5 
Density  Predominantly Solid  
Predominantly 
Cystic 
Mixed 
Calcification Fine  
Coarse 
Serosal implants / involvement     
Liver    Enlarged   
Focal lesions 
IHBRD   
Fissural involvement    
 Scalloping    
Spleen Enlarged    
Focal lesions    
Lymphadenopathy Station  Mediastinal   
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 Diaphragmatic  
 Lesser Omental  
 Greater Omental 
 Mesenteric  
 Para-aortic 
 Para-iliac 
Necrosis   
Ovarian masses / involvement   NA   
Bowel obstruction    
Terminal ileum or cecal thickening    
Ascites  Free    
Loculated  
Attenuation  < 20 HU 
> 20 HU 
Pleural effusion  UL BL   
Any other significant finding 
 
 
 
  
 
Radiological diagnosis:                 Radiological diagnosis 2:  
(Observer 1)                                  (Observer 2) 
 
Histopathology diagnosis (Omental biopsy): 
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Radiological diagnosis: 
1. TB  
2. Carcinomatosis 
3. Lymphomatosis 
4. Equivocal findings  
5. Primary peritoneal malignancy  
6. Pseudomyxoma peritonei 
7. Others  
Histopathological diagnosis: 
1. Necrotizing / caseating granulomatous inflammation, s/o TB  
2. Non-specific chronic inflammation  
3. Metastatic adenocarcinoma  
4. Lymphoma  
5. Pseudomyxoma peritonei 
6. Malignant mesothelioma  
7. Primary peritoneal carcinoma  
8. Amyloidosis  
9. Metastatic GIST 
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APPENDIX – 3 DATA SHEETS 
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608
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2 3
1 
930
190
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3 2
2 
566
039
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2 
    
2 2 1 23.2 2 1 2 
    
1 2 2 
4 3
3 
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344
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5 4
3 
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636
H 
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1 2 2 
6 1
8 
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712
H 
2 1 5.4 2 1 2 2 1 
 
2 2 1 20 1 1 1 2 2 1 
 
2 2 2 
7 4
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